IDT Australia Ltd
ASX:IDT
IDT Australia Ltd
EPS (Diluted)
IDT Australia Ltd
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
IDT Australia Ltd
ASX:IDT
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-15%
|
CAGR 10-Years
14%
|
|
Mayne Pharma Group Ltd
ASX:MYX
|
EPS (Diluted)
AU$1
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
EPS (Diluted)
AU$1
|
CAGR 3-Years
N/A
|
CAGR 5-Years
111%
|
CAGR 10-Years
N/A
|
|
Botanix Pharmaceuticals Ltd
ASX:BOT
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
0%
|
CAGR 5-Years
20%
|
CAGR 10-Years
27%
|
|
Probiotec Ltd
ASX:PBP
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
26%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
10%
|
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
-44%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is IDT Australia Ltd's EPS (Diluted)?
EPS (Diluted)
-0
AUD
Based on the financial report for Dec 31, 2023, IDT Australia Ltd's EPS (Diluted) amounts to -0 AUD.
What is IDT Australia Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
14%
Over the last year, the EPS (Diluted) growth was 33%.